ArticleBMC pharmacology & toxicology2025

Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004-2024).

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.